Fulgent Genetics
FLGT
183 hedge funds and large institutions have $350M invested in Fulgent Genetics in 2024 Q3 according to their latest regulatory filings, with 33 funds opening new positions, 49 increasing their positions, 57 reducing their positions, and 22 closing their positions.
14,043% more call options, than puts
Call options by funds: $44.4M | Put options by funds: $314K
50% more first-time investments, than exits
New positions opened: 33 | Existing positions closed: 22
17% more capital invested
Capital invested by funds: $299M → $350M (+$50.4M)
6% more funds holding
Funds holding: 173 → 183 (+10)
2.14% more ownership
Funds ownership: 50.97% → 53.11% (+2.1%)
14% less repeat investments, than reductions
Existing positions increased: 49 | Existing positions reduced: 57
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
+$6.97M |
| 2 |
Point72 Asset Management
Stamford,
Connecticut
|
+$6.02M |
| 3 |
Acadian Asset Management
Boston,
Massachusetts
|
+$5.32M |
| 4 |
JP Morgan Chase
New York
|
+$4.01M |
| 5 |
ICM
Invenomic Capital Management
Boston,
Massachusetts
|
+$2.78M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DSCM
Divisadero Street Capital Management
Miami,
Florida
|
-$9.91M |
| 2 |
PWAM
Park West Asset Management
San Francisco,
California
|
-$2.68M |
| 3 |
Dimensional Fund Advisors
Austin,
Texas
|
-$2.46M |
| 4 |
D.E. Shaw & Co
New York
|
-$1.69M |
| 5 |
Norges Bank
Oslo,
Norway
|
-$1.67M |
FLGT Hedge Fund Activity: Q3 2024 in Review
183 of the 6,965 institutional investors tracked by Wall St. Rank reported a position in Fulgent Genetics (FLGT) for Q3 2024, worth a combined $350M — up 17% from $299M a quarter earlier.
Buyers outnumbered sellers: 33 funds opened new FLGT positions and 22 closed out — a net gain of 11 holders — while 49 added to existing stakes and 57 trimmed.
The largest buyer was Millennium Management, adding an estimated $6.97M. The largest seller was Divisadero Street Capital Management, exiting entirely with an estimated $9.91M sold.
- 183 institutional investors held Fulgent Genetics (FLGT) as of Q3 2024, up from 173 in Q2 2024.
- Funds reported $350M of Fulgent Genetics stock for Q3 2024, up 17% quarter-over-quarter.
- 33 funds opened new Fulgent Genetics positions in Q3 2024 and 22 closed out, a net change of +11 holders.
- The largest Fulgent Genetics buyer in Q3 2024 was Millennium Management, an estimated $6.97M added.
- The largest Fulgent Genetics seller in Q3 2024 was Divisadero Street Capital Management, an estimated $9.91M sold.
Based on aggregated 13F filings for Q3 2024.